Startups, BioPharma This week on MedHeads: A look back at the 2016 JP Morgan Healthcare Conference By Nicole Oran
Devices & Diagnostics Strategy tips for the JP Morgan healthcare conference (and what comes after) By Chelli Miller
Daily What to expect when you’re expecting… a lot out of the JP Morgan Healthcare Conference By Meghana Keshavan
Devices & Diagnostics Easily the best tweet from the JP Morgan Healthcare Conference (#jpm12) By Chris Seper
MedCity Influencers, Devices & Diagnostics Overcoming Hearing Healthcare Barriers to Realize Gene Therapy Promise By
MedCity Influencers, BioPharma, Health Tech Key Trends from the 2024 J.P. Morgan Healthcare Conference By Sujay Jadhav
BioPharma, Pharma At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy By Frank Vinluan
Daily, BioPharma What Was the Most-Repeated Word in CVS Health CEO’s JPM Presentation? By Arundhati Parmar
MedCity Influencers, BioPharma After JPM, What Are the Legal Dealmaking Trends to Watch? By Thomas Rose and Heather Morehouse Ettinger
